학술논문

Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts
Document Type
Article
Source
In The Lancet Rheumatology October 2022 4(10):e699-e709
Subject
Primary Research
Articles
Language
ISSN
2665-9913